Amprius business momentum is clear, but the stock already reflects much of it
Amprius is executing like a company in breakout mode, yet the shares already trade at what appears to be a rich price for that story. Bulls can point to Q1 revenue of $28.5 million, which grew 2.5x year over year, and to management's revised 2026 revenue outlook of at least $130.0 million. Bears look at the same setup and argue the easy optimism is gone: with a $2.13 billion market cap, AMPX is trading at a 738% premium to Morningstar fair value of $43.65, even though Morningstar assigns very high uncertainty.
The key question is no longer whether Amprius has a credible story. It is whether the stock is still early. Price action suggests sentiment is still doing a lot of the work. The shares are up 84.3% year to date, but they also just lived through a 27% one-day drop and a 24% weekly decline. That kind of tape often reflects FOMO and panic in quick succession rather than calm fundamental repricing.
The practical takeaway is simple: the business appears to be improving faster than many models expected, but the stock may already be pricing much of that progress.
Improving gross profit, not just headlines, is supporting the premium
Q1 economics look more constructive
The market is not paying up for a story alone. It is paying up because the economics are starting to look more real. The most important number is not just revenue growth. It is gross profit improving 343% YoY in Q1, alongside a 20% GAAP gross margin that would have been 22% excluding nonrecurring Colorado expenses. That is consistent with early operating leverage: as output rises, fixed manufacturing costs are spread across more units and the income statement starts to respond faster than costs.
That matters because a hype cycle can survive weak demand for a while, but it usually cannot do so while gross profit keeps improving. Amprius already showed that trajectory in late 2025, when Q4 2025 gross margin improved to 24% and the company posted its first positive quarterly non-GAAP adjusted EBITDA of $1.8 million.
Profitability remains a target, not a track record
Q1 extended that direction. Amprius reported net loss of $5.0 million, a 46% improvement year over year, while lifting its 2026 revenue outlook to at least $130.0 million. Management also reiterated targets for net loss below $8.0 million and positive non-GAAP adjusted EBITDA of at least $4.0 million.
One quarter does not prove durability, but it does make the bullish case stronger. Amprius is not just growing; it is also narrowing losses while expanding its outlook.
Why dilution concerns matter less now
That helps explain why the premium feels less arbitrary than it did a year ago. Amprius entered 2026 with no debt, and bullish investor commentary centered on a path to profitability within one to two quarters, no open ATM, and a lower need to raise capital. If that stays true, equity overhang should be less of an issue.
Customer breadth also matters. Management tied Q1 sequential growth to existing drone customers and new end markets, while highlighting a $21.0 million purchase order from a light electric vehicle customer. A business with traction across drones, LEVs, and adjacent niches looks more resilient than one dependent on a single program.
The stock's behavior raises valuation risk even if the business story is real
Recent price action can crowd out disciplined thinking
Once Amprius posted Q1 revenue of $28.5 million and lifted its 2026 outlook, investors had a genuine operating inflection to reward. But price soon started doing much of the thinking. After an 84.3% year-to-date share price return, the stock began trading less like a company still proving durability and more like a narrative investors feared missing.
That is where behavioral bias comes in. After a sharp run, investors can mistake the most recent surge for a base case. The recent 27% one-day drop and 24% weekly decline show how quickly that mood can reverse.
Confirmation bias can make rich valuations harder to question
Bulls have real evidence to point to: gross profit improving 343% YoY, Q4 2025 gross margin improved to 24%, and the first positive quarterly non-GAAP adjusted EBITDA of $1.8 million. But confirmation bias can still distort the debate by emphasizing the best data points and downplaying how much future execution the stock already requires.
That is the core risk now. Morningstar still shows a 738% premium with very high uncertainty. That does not mean the stock cannot stay expensive. It does mean the market is valuing near-consistent execution, not just a credible turnaround.
What to watch in June 2026 to judge whether the premium holds
The next checkpoint is whether operations keep earning the premium. A useful near-term marker is the June 2026 events schedule. After record Q1 revenue and the company's increased 2026 outlook, investors should separate business quality from stock attractiveness.
Signals that would support the current multiple
- Revenue continues to advance in line with or above management's 2026 targets.
- Gross margin stays near or above the Q1 GAAP level of 20%, or 22% excluding the nonrecurring Colorado expenses.
- Losses keep narrowing from the Q1 net loss of $5.0 million.
- The company avoids another equity raise, consistent with the view that Amprius shouldn't need to raise anymore capital.
Signals that would pressure the stock
- Guidance stalls after the recent upgrade.
- Margin gains fade once the one-time Colorado benefit is fully reflected.
- Profitability slips again after positive non-GAAP adjusted EBITDA first appeared.
- Demand remains concentrated in too few customers or end markets.